ArticleRSC advances2026
Rational design and synthesis of new acetamide-indole-benzo[
Navid Dastyafteh, Seyedeh Niloufar Ghafouri, Marjan Mollazadeh, Nazanin Motamedi Shakib, Mohammad Halimi, Samanesadat Hosseini, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Bagher Larijani, Massoud Amanlou and 2 more
Abstract read
In one paragraphArticle in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Navid DastyaftehCenter for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences Tehran Iran.
Seyedeh Niloufar GhafouriSchool of Chemistry, College of Science, University of Tehran Tehran Iran.
Marjan MollazadehEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
Nazanin Motamedi ShakibSchool of Chemistry, College of Science, University of Tehran Tehran Iran.
Mohammad HalimiDepartment of Biology, Babol Branch, Islamic Azad University Babol Iran.
Samanesadat HosseiniDepartment of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences Tehran Iran.
Bagher LarijaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.
Maryam Mohammadi-KhanaposhtaniCellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences Babol Iran maryammoha@gmail.com.ORCID https://orcid.org/0000-0001-7664-9664 Mohammad MahdaviEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences Tehran Iran momahdavi@tums.ac.ir.ORCID https://orcid.org/0000-0002-8007-2543 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
A series of novel acetamide-indole-benzo[
Identifiers
PMID41602177
PMCPMC12833917
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390